Geode Capital Management’s Response Genetics RGDX Stock Holding History
Bought
Maintained
Sold
Geode Capital Management's RGDX Position: Q3 2015 in Review
Geode Capital Management sold out of Response Genetics (RGDX) in Q3 2015, closing a stake of 99,700 shares — an estimated $32K sold.
Geode Capital Management first reported a position in RGDX in Q1 2014 and held it in 6 quarters. The position peaked at $91K in Q2 2014. 1 fund tracked by Wall St. Rank holds RGDX as of Q3 2015.
- Geode Capital Management reported no remaining Response Genetics position as of Q3 2015 after selling out during the quarter.
- Geode Capital Management sold 99,700 Response Genetics shares in Q3 2015, an estimated $32K.
- Geode Capital Management first reported a position in Response Genetics in Q1 2014 and held it in 6 quarters.
- Geode Capital Management's Response Genetics position peaked at $91K in Q2 2014.
- 1 fund tracked by Wall St. Rank held Response Genetics as of Q3 2015.
Based on Geode Capital Management's 13F filing for Q3 2015, filed 13 Nov 2015.